Hypera plans to introduce a generic version of semaglutide in Brazil following patent expiration in 2026. The company is optimistic about market growth despite potential price impacts. Analysts ...

Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...

The drug — along with Novo Nordisk’s semaglutide marketed as Wegovy — has been much ... Eli Lilly for importing and marketing the medicine in a single dose pre-filled pen and in a single-dose vial in ...